Integrated Report

Fulfilling Moments, Enriching Life

Integrated Report2025

key messages

Special feature: Interview with the Chairperson and CEO

Read more

40th anniversary of incorporation
— the JT Group’s past and future

40th anniversary of incorporation
- the JT Group’s past and future

Representative Director and President, Chief Executive Officer

Masamichi Terabatake

CEO message

Toward further growth of the JT Group

Toward further growth of the JT Group

Senior Vice President
Chief Sustainability Officer

Hisato Imokawa

CSO message

Only when nature and society are sustainable can businesses and people's lives be sustainable

Only when nature and society are sustainable can businesses and people's lives be sustainable

Senior Vice President,
Chief Financial Officer

Hiromasa Furukawa

CFO message

JT Group's strong financial base and strategy

JT Group's strong financial base and strategy

Roundtable Discussion with Outside Directors

Read more

Challenges and expectations for the growth of the JT Group through dialogue with the capital markets

Challenges and expectations for the growth of the JT Group through dialogue with the capital markets

contents

While on May 7th, 2025, the Company announced entering into an agreement with Shionogi & Co., Ltd to transfer the pharmaceutical business and our stake in TORII PHARMACEUTICAL CO., LTD. (“Torii”), a consolidated subsidiary of JT, the JT Group’s performance and initiatives described in this report include those associated with the pharmaceutical business and Torii. Please see the press releases on our website for the details.

PHARMACEUTICAL
BUSINESS

Related links